Federal Register: February 19, 2008 (Volume 73, Number 33)
DOCID: fr19fe08-29 FR Doc E8-2980
DEPARTMENT OF DEFENSE
Army Department
NOTICE: NOTICES
DOCID: fr19fe08-29
ACTION: Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing:
DOCUMENT ACTION: Notice.
SUBJECT CATEGORY:
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of Invention Described in U.S. Provisional Patent Application Concerning Treatment of Ischemia-Reperfusion Injury with Lipid, Annexin, and Lipid-Annexin Complexes
DOCUMENT SUMMARY:
In accordance with 37 CFR 404.4, 404.6 and 404.7, announcement is made of the availability for licensing of the invention described in U.S. Provisional Patent Application No. 60/786,527 entitled ``Treatment of IschemiaReperfusion Injury with Lipid, Annexin, and LipidAnnexin Complexes,'' filed March 27, 2006. Foreign rights are also available (PCT/US2007/065125). The United States Government, as represented by the Secretary of the Army, has rights in this invention.
SUMMARY:
Invention Described in U.S. Provisional Patent Application—; Treatment of Ischemia-Reperfusion Injury With Lipid, Annexin, and Lipid-Annexin Complexes,
SUPPLEMENTAL INFORMATION
Disclosed are lipids, annexin, and lipid-
annexin complexes for use in the prevention and/or treatment of
ischemiareperfusion injury and reperfusion injury associated with a
variety of diseases and conditions. Also disclosed are therapeutic
targets and compositions for the prevention and treatment of ischemia
reperfusion injury and diseases and conditions associated with ischemiareperfusion injury.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. E82980 Filed 21508; 8:45 am]
BILLING CODE 371008P
FOR FURTHER INFORMATION CONTACT
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 6197808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 6196664, both at telefax (301) 6195034.